Seguir
Pierosandro Tagliaferri
Título
Citado por
Citado por
Ano
Mir-34: a new weapon against cancer?
G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ...
Molecular therapy-nucleic acids 3, 2014
5982014
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
P Tassone, P Tagliaferri, A Perricelli, S Blotta, B Quaresima, ML Martelli, ...
British journal of cancer 88 (8), 1285-1291, 2003
4602003
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
N Amodio, L Raimondi, G Juli, MA Stamato, D Caracciolo, P Tagliaferri, ...
Journal of hematology & oncology 11, 1-19, 2018
3132018
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
2612012
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy
P Correale, MS Rotundo, MT Del Vecchio, C Remondo, C Migali, ...
Journal of immunotherapy 33 (4), 435-441, 2010
2492010
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
E Leone, E Morelli, MT Di Martino, N Amodio, U Foresta, A Gullà, M Rossi, ...
Clinical Cancer Research 19 (8), 2096-2106, 2013
2372013
Familial papillary thyroid microcarcinoma: a new clinical entity
G Lupoli, G Vitale, M Caraglia, MR Fittipaldi, A Abbruzzese, P Tagliaferri, ...
The Lancet 353 (9153), 637-639, 1999
2371999
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
N Amodio, MA Stamato, G Juli, E Morelli, M Fulciniti, M Manzoni, E Taiana, ...
Leukemia 32 (9), 1948-1957, 2018
2242018
miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease
M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ...
Journal of cellular physiology 228 (7), 1506-1515, 2013
2072013
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
P Tassone, P Tagliaferri, C Viscomi, C Palmieri, M Caraglia, ...
British journal of cancer 88 (12), 1971-1978, 2003
2072003
A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life
F Zullo, S Palomba, T Russo, A Falbo, M Costantino, A Tolino, E Zupi, ...
American journal of obstetrics and gynecology 193 (4), 1344-1352, 2005
2012005
Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines
P Tassone, S Forciniti, E Galea, G Morrone, MC Turco, V Martinelli, ...
Leukemia 14 (5), 841-844, 2000
1992000
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic “dark matter”
K Grillone, C Riillo, F Scionti, R Rocca, G Tradigo, PH Guzzi, S Alcaro, ...
Journal of Experimental & Clinical Cancer Research 39, 1-19, 2020
1962020
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
1942012
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials
D Ciliberto, C Botta, P Correale, M Rossi, M Caraglia, P Tassone, ...
European journal of cancer 49 (3), 593-603, 2013
1752013
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ...
Oncotarget 3 (10), 1246, 2012
1752012
Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial
F Zullo, S Palomba, A Falbo, T Russo, R Mocciaro, E Tartaglia, ...
American journal of obstetrics and gynecology 200 (3), 296. e1-296. e9, 2009
1742009
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma
MT Di Martino, A Gullà, MEG Cantafio, M Lionetti, E Leone, N Amodio, ...
Oncotarget 4 (2), 242, 2013
1662013
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma
S Blotta, J Jakubikova, T Calimeri, AM Roccaro, N Amodio, AK Azab, ...
Blood, The Journal of the American Society of Hematology 120 (25), 5002-5013, 2012
1612012
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
MT Di Martino, V Campani, G Misso, ME Gallo Cantafio, A Gulla, ...
PloS one 9 (2), e90005, 2014
1412014
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20